June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Deciphering ELOVL4 mutant activity in retinal degeneration
Author Affiliations & Notes
  • Yeboah Kofi Gyening
    Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Neeraj Kumar Chauhan
    Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Vicki Ea
    Ophthalmology and Dean Mcgee Eye Institute, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Madison Tytanic
    Ophthalmology and Dean Mcgee Eye Institute, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Richard Steve Brush
    Ophthalmology and Dean Mcgee Eye Institute, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Robert E Anderson
    Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
    Ophthalmology and Dean Mcgee Eye Institute, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Martin-Paul Gameli Agbaga
    Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
    Ophthalmology and Dean Mcgee Eye Institute, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Footnotes
    Commercial Relationships   Yeboah Gyening None; Neeraj Chauhan None; Vicki Ea None; Madison Tytanic None; Richard Brush University of Oklahoma Health Science Center, Code P (Patent); Robert Anderson University of Oklahoma Health Science Center, Code P (Patent); Martin-Paul Agbaga University of Oklahoma Health Science Center, Code P (Patent)
  • Footnotes
    Support  R01 EY030513 and R21 AR076035 and the Oklahoma Center for Advancement of Science and Technology (OCAST) (MPA) and NIH grants R01EY04149, P30EY021725, and unrestricted grant support from Research to Prevent Blindness to the Dean McGee Eye Institute
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3169 – F0443. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yeboah Kofi Gyening, Neeraj Kumar Chauhan, Vicki Ea, Madison Tytanic, Richard Steve Brush, Robert E Anderson, Martin-Paul Gameli Agbaga; Deciphering ELOVL4 mutant activity in retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3169 – F0443.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : ELOngation of Very Long-chain fatty acids-4 (ELOVL4) is an enzyme that catalyzes the biosynthesis of very long chain saturated (VLC-SFA) and polyunsaturated (VLC-PUFA) fatty acids, collectively known as very long chain fatty acids (VLC-FA). ELOVL4 is only expressed in the retina, brain, skin, testis, and Meibomian glands. Different mutations in ELOVL4 affect these tissues in different ways. Some known mutations in humans only affect the retina causing a juvenile form of macular degeneration known as Autosomal Dominant Stargardt-like Macular Dystrophy (STGD3), while other mutations affect the brain and/or skin leading to Spinocerebellar Ataxia-34 (SCA34) and skin lesions. How the different ELOVL4 mutations cause such different tissue-specific pathologies are not well understood. We hypothesize that the various mutant ELOVL4 enzymes synthesize less and varying amounts of VLC-FA in a tissue-specific manner to cause the different tissue-specific pathologies.

Methods : We transduced ELOVL4 variants (L168S, L168F, W246G, and STGD3) in human embryonic kidney cells (HEK 293T) or human retinal epithelial cells (ARPE-19) and treated the cells with VLC-FA precursors lignoceric acid (24:0) and eicosapentaenoic acid (EPA; 20:5n3). The cells were harvested for fatty acid analyses to determine the level of VLC-FA biosynthesis. The effect of the different ELOVL4 variants on cell health was also examined using cell-based assays.

Results : The truncated ELOVL4 mutations that cause STGD3 did not synthesize VLC-FA. However, the SCA34 proteins, although enzymatically active, synthesized lesser quantities of VLC-FA than that of wild-type ELOVL4. Further, the accumulation of mutant ELOVL4 protein triggers endoplasmic reticulum (ER) stress through the eIF2α–ATF4 pathway and leads to cell death. We were able to alleviate the ER stress and cell death by supplementation with unsaturated fatty acids (EPA) while saturated fatty acids (24:0) exacerbated cell death.

Conclusions : The SCA34 ELOVL4 proteins make less VLC-FA product and promote cell death via ER stress, which can be alleviated with EPA supplementation. Future experiments will delve deeper into understanding the mechanisms of retinal degeneration in ELOVL4-related diseases.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×